Valo Health enters $2.7B pact with Novo Nordisk to develop heart drugs

The Denmark drug giant will use Valo’s platform that uses real-world patient data and AI computation to speed up the delivery and development process.

Previous How this Saratoga company grew revenue more than 2,000% in three years
Next Kentucky-based smoothie company Better Blend to open first area location in St. Matthews